Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Cognition and GBA[original query] |
|---|
| Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease. JIMD reports 2014 16 31-8. Barrett M J, Shanker V L, Severt W L, Raymond D, Gross S J, Schreiber-Agus N, Kornreich R, Ozelius L J, Bressman S B, Saunders-Pullman |
| GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study. Movement disorders : official journal of the Movement Disorder Society 2015 Mar 30 (3): 407-11. Brockmann Kathrin, Srulijes Karin, Pflederer Sylvia, Hauser Ann-Kathrin, Schulte Claudia, Maetzler Walter, Gasser Thomas, Berg Danie |
| A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype. Parkinsonism & related disorders 2016 Dec . Thaler Avner, Gurevich Tanya, Bar Shira Anat, Gana Weisz Mali, Ash Elissa, Shiner Tamara, Orr-Urtreger Avi, Giladi Nir, Mirelman An |
| High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews. JAMA neurology 2016 Oct . Shiner Tamara, Mirelman Anat, Gana Weisz Mali, Bar-Shira Anat, Ash Elissa, Cialic Ron, Nevler Naomi, Gurevich Tanya, Bregman Noa, Orr-Urtreger Avi, Giladi N |
| Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease. Parkinsonism & related disorders 2018 Aug . Liu Shu-Ying, Zheng Zheng, Gu Zhu-Qin, Wang Chao-Dong, Tang Bei-Sha, Xu Yan-Ming, Ma Jing-Hong, Zhou Yong-Tao, Feng Tao, Chen Sheng-Di, Chan Piu, |
| Progression in the LRRK2-Asssociated Parkinson Disease Population. JAMA neurology 2018 1 75 (3): 312-319. Saunders-Pullman Rachel, Mirelman Anat, Alcalay Roy N, Wang Cuiling, Ortega Roberto A, Raymond Deborah, Mejia-Santana Helen, Orbe-Reilly Martha, Johannes Brooke A, Thaler Avner, Ozelius Laurie, Orr-Urtreger Avi, Marder Karen S, Giladi Nir, Bressman Susan B, |
| Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study. Journal of neurology, neurosurgery, and psychiatry 2018 Jul 89 (7): 702-709. Malek Naveed, Weil Rimona S, Bresner Catherine, Lawton Michael A, Grosset Katherine A, Tan Manuela, Bajaj Nin, Barker Roger A, Burn David J, Foltynie Thomas, Hardy John, Wood Nicholas W, Ben-Shlomo Yoav, Williams Nigel W, Grosset Donald G, Morris Huw R, |
| Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease. Neuroscience letters 2020 May 135034. Liu Hong-Jun, Li Xiao-Yan, Chen Hui, Yu Hui-Li, Tao Qing-Qing, Wu Zhi-Yi |
| Disease Progression in Patients with Parkin-Related Parkinson's Disease in a Longitudinal Cohort. Movement disorders : official journal of the Movement Disorder Society 2020 10 36 (2): 442-448. Sun Yi-Min, Yu Hui-Ling, Zhou Xin-Yue, Xiong Wei-Xi, Luo Su-Shan, Chen Chen, Liu Feng-Tao, Zhao Jue, Tang Yi-Lin, Liang Xiao-Niu, Yang Yu-Jie, Shen Bo, Shen Yan, Yu Wen-Bo, Ding Zheng-Tong, An Yu, Wu Jian-Jun, Wang Ji |
| Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease. Parkinsonism & related disorders 2021 8 90 84-89. Schejter-Margalit Tamara, Kizony Rachel, Shirvan Julia, Cedarbaum Jesse M, Bregman Noa, Thaler Avner, Giladi Nir, Mirelman An |
| The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews. Journal of Alzheimer's disease : JAD 2021 Feb . Shiner Tamara, Mirelman Anat, Rosenblum Yevgenia, Kavé Gitit, Weisz Mali Gana, Bar-Shira Anat, Goldstein Orly, Thaler Avner, Gurevich Tanya, Orr-Urtreger Avi, Giladi Nir, Bregman N |
| Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers. Frontiers in neurology 2021 3 12 635958. Moran Eileen E, Bressman Susan B, Ortega Roberto A, Raymond Deborah, Nichols William C, Palmese Christina A, Elango Sonya, Swan Matthew, Shanker Vicki, Perera Imali, Wang Cuiling, Zimmerman Molly E, Saunders-Pullman Rach |
| Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's disease. NPJ Parkinson's disease 2022 Jun 8 (1): 78. Morris Rosie, Martini Douglas N, Ramsey Katrina, Kelly Valerie E, Smulders Katrijn, Hiller Amie, Chung Kathryn A, Hu Shu-Ching, Zabetian Cyrus P, Poston Kathleen L, Mata Ignacio F, Edwards Karen L, Lapidus Jodi, Cholerton Brenna, Montine Thomas J, Quinn Joseph F, Horak F |
| Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Annals of neurology 2022 1 91 (3): 424-435. Pal Gian, Mangone Graziella, Hill Emily J, Ouyang Bichun, Liu Yuanqing, Lythe Vanessa, Ehrlich Debra, Saunders-Pullman Rachel, Shanker Vicki, Bressman Susan, Alcalay Roy N, Garcia Priscilla, Marder Karen S, Aasly Jan, Mouradian M Maral, Link Samantha, Rosenbaum Marc, Anderson Sharlet, Bernard Bryan, Wilson Robert, Stebbins Glenn, Nichols William C, Welter Marie-Laure, Sani Sepehr, Afshari Mitra, Verhagen Leo, de Bie Rob M A, Foltynie Tom, Hall Deborah, Corvol Jean-Christophe, Goetz Christopher |
| Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 Variants. Journal of Parkinson's disease 2024 5 . Ethan G Brown, Samuel M Goldman, Christopher S Coffey, Andrew Siderowf, Tanya Simuni, Cheryl Meng, Michael C Brumm, Chelsea Caspell-Garcia, Kenneth Marek, Caroline M Tanner, |
| GBA moderates cognitive reserve's effect on cognitive function in patients with Parkinson's disease. Journal of neurology 2024 4 . Chia-Wen Chang, Chun-Hsiang Tan, Wei-Pin Hong, Rwei-Ling |
| Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers. NPJ Parkinson's disease 2024 4 10 (1): 88. Benjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, Milan Zimmermann, Isabel Wurster, Ulrike Sünkel, Claudia Schulte, Christian Deuschle, Gerhard W Eschweiler, Walter Maetzler, Thomas Gasser, Daniela Berg, Kathrin Brockma |
- Page last reviewed:Feb 1, 2024
- Content source: